linjc16/ctgov huggingface dataset:
Changes of Upper and Lower Limb Blood Flow and Vascular Resistance in Hyperbaric Spinal Anesthesia for Transurethral Resection of the Prostate (TURP) Using Duplex Ultrasonography: Comparison of Normotensive and Hypertensive Patients

Study Overview
=================
Brief Summary
-----------------
Changes of Upper and Lower Limb Blood Flow and Vascular Resistance in Hyperbaric Spinal Anesthesia for TURP Using Duplex Ultrasonography: Comparison of Normotensive and Hypertensive Patients.

Conditions
-----------------
Transurethral Resection of the Prostate (TURP)

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: males (> 65 yr) were scheduled to have spinal anaesthesia for TURP Exclusion Criteria: patients with peripheral vascular disease chronic venous insufficiency prior deep vein thrombosis (DVT) defined by the presence of thrombosis on duplex or the presence of ultrasonographic signs indicating a previous DVT body mass index >35 prior lower limb surgery due to arterial or venous trauma history of diabetes or autonomic deficiency.

Ages Eligible for Study
-----------------
Minimum Age: 65 Years

Sexes Eligible for Study
-----------------
Male

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Hypertensive and normotensive<br> | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| venous flow velocity, blood volume flow, resistance index, pulsatility index, diameter of popliteal vein |  | 10 minutes after spinal block | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Male patients scheduled to have spinal anaesthesia for TURP
Group Training for Social Skills in Psychosis

Study Overview
=================
Brief Summary
-----------------
The purpose of this study is to assess the feasibility of a social skills training group for people with psychosis.

Detailed Description
-----------------
This study is assessing the feasibility of a psychological intervention targeting social cognition problems in people with psychosis. The intervention is a group psychological treatment facilitated by a clinical psychologist. The group therapy takes advantage of audiovisual material and practical exercises to illustrate strategies and thinking styles that may help participants overcome difficulties in social settings. A second objective of this study is to test a new method to measure social cognition by using portable devices. These devices will be carried by participants in their everyday life and will ask about their social activity levels at random times and record activity levels.

Official Title
-----------------
Exploring the Feasibility of Social Skills Training in People With Psychosis.

Conditions
-----------------
Psychotic Disorders

Intervention / Treatment
-----------------
* Behavioral: GRASP
* Behavioral: Standard care


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Diagnosis part of the psychosis spectrum (according to DSM-IV or DSM-V or ICD-10) Good command of the English language Social engagement problems as evidenced by care coordinator report and number of hours spent in social activities per week lower than 10. Exclusion Criteria: Primary diagnosis of substance abuse disorder Change in antipsychotic medication in the last six weeks Significant learning difficulties (premorbid IQ lower than 70)

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 65 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Treatment
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: GRASP<br>GRoup trAining for Social skills in Psychosis | Behavioral: GRASP<br>* GRoup trAining for Social skills in Psychosis<br>|
| Active Comparator: Standard care<br>Treatment as usual as provided by care team | Behavioral: Standard care<br>* Treatment as usual<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Therapy drop-out rate |  | 8 weeks post randomisation | 
| Number of therapy session attended |  | 8 weeks post randomisation | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Psychosis, Schizophrenia, Social Skills, Therapy
Longitudinal Population-based Observational Study of COVID-19 in the UK Population

Study Overview
=================
Brief Summary
-----------------
COVIDENCE UK is a population-based observational longitudinal study that has the following objectives: To determine risk factors for incident COVID-19 and for adverse outcomes of COVID-19 in the UK population To characterise the natural history of COVID-19 in the UK population To evaluate the impact of COVID-19 on the physical and mental health of the UK population To provide a resource from which to identify potential participants for future clinical trials, and to use data collected in COVIDENCE as comparison or control data for trial participants who have been randomised to receive one or more interventions.

Official Title
-----------------
Longitudinal Population-based Observational Study of COVID-19 in the UK Population

Conditions
-----------------
COVID-19

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: UK resident Age ≥16 years Exclusion Criteria: none

Ages Eligible for Study
-----------------
Minimum Age: 16 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------
What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Incidence of confirmed COVID-19 |  | 5 years | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Incidence of probable or suspected COVID-19 |  | 5 years | 
| Incidence of COVID-19 requiring hospitalisation |  | 5 years | 
| Incidence of COVID-19 requiring ventilatory support |  | 5 years | 
| Incidence of fatal COVID-19 |  | 5 years | 
| Symptom duration per COVID-19 episode |  | 5 years | 
| Symptom severity per COVID-19 episode |  | 5 years | 
| Incidence of seroconversion to SARS-CoV-2 |  | 5 years | 
| Incidence of recurrent COVID-19 |  | 5 years | 
| EQ-5D-3L health-related quality of life score |  | 5 years | 
| Health care costs associated with incident COVID-19 |  | 5 years | 
| Impact of the COVID-19 pandemic and the societal response on participants' financial status |  | 5 years | 
| Incidence of COVID-19 on participant's physical health |  | 5 years | 
| Impact of COVID-19 on participants' mental health |  | 5 years | 
| Impact of COVID-19 on physical health of offspring born to participants during follow-up |  | 5 years |
Ultrasound Evaluation of Gastric Emptying in Diabetic Patients

Study Overview
=================
Brief Summary
-----------------
This is a prospective cohort study. The main objective is to compare the frequency of a full stomach in the diabetic population compared to healthy controls 2 h after clear liquid and 6h after a light meal, and evaluate the mean gastric emptying time of clear liquid and light meal in diabetic patients.

Official Title
-----------------
A Cohort Study of Ultrasound Evaluation of Gastric Emptying in Diabetic Patients: a Comparison With Healthy Controls

Conditions
-----------------
Diabetes

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Diabetic and non-diabetic Patients scheduled for elective surgery aged 18 to 85years American Society of Anesthesia physical status classification I to III Body mass index < 40 kg/ cm2. Exclusion Criteria: Pregnancy (currently or within the past 3 months) Previous surgery of the upper gastrointestinal tract Achalasia

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 85 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| diabetic patients<br> | |
| healthy control<br> | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Number of patients with full stomach | The main objective is to compare the frequency of a full stomach in the diabetic population compared to a healthy control population 2h after clear liquid or 6h after light meal. | one day | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| the mean gastric emptying time of clear liquid and light meal | To assess the mean gastric emptying time of clear liquid and light meal in the diabetic population | one day |
Loss to Follow-up in PDR Patients

Study Overview
=================
Brief Summary
-----------------
This study determined the clinical impact and causes of loss to follow-up (LTFU) from the patients' perspective in individuals with proliferative diabetic retinopathy (PDR) who received panretinal photocoagulation (PRP) and/or intravitreal injections (IVIs) of anti-vascular endothelial growth factor (VEGF). This prospective cohort study included 467 patients with PDR who received PRP and/or IVIs of anti-VEGF between May 2013 and June 2018. LTFU was defined as missing any follow-up visit for any interval exceeding 6 months, provided that patients eventually resumed care. Main outcome measures include rates and causes of LTFU.

Official Title
-----------------
Causes and Clinical Impact of Loss to Follow-up in Patients With Proliferative Diabetic Retinopathy

Conditions
-----------------
Diabetic Retinopathy

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: included treatment-naïve patients who had developed PDR in one eye with a best corrected visual acuity (BCVA) ranging from 20/22 to 20/69, as determined by the Snellen equivalent. Patients were allocated to receive PRP, IVIs of anti-VEGF, or a combination of both procedures. Exclusion Criteria: patients receiving follow-up ophthalmic care for their PDR with or without interventions at any other medical care provider during the observation period, as declared by the patients at any follow up visit. patients LTFU who did not resume follow-up until the end of the observation period. patients needing PPV at first presentation or having additional retinal pathology. 4) patients receiving their treatment procedure during December 2017 or having vitreous hemorrhage that failed to clear up by June 2018 but still ineligible candidates for PPV.

Ages Eligible for Study
-----------------
Minimum Age: 40 Years
Maximum Age: 70 Years

Sexes Eligible for Study
-----------------
All

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Compliant patients<br>The compliant patient was defined as a patient who did not miss any follow-up visit until the end of the study period. | |
| Loss to follow-up (LTFU)<br>LTFU was defined as missing any follow-up visit for any interval exceeding 6 months provided that patients eventually resumed care before the end of the study period (time zero was defined as the date of the missed follow-up visit). | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Final BCVA | logMAR BCVA at final follow up (Snellen equivalent) | through study completion, an average of 1 year, | 
| Final UCVA | Final logMAR UCVA (Snellen equivalent) | through study completion, an average of 1 year, | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
loss to follow-up, proliferative diabetic retinopathy, diabetic retinopathy, panretinal photocoagulation, intravitreal injections
Development of a Segmental Bioelectrical Impedance Spectroscopy Device for Body Composition Measurement

Study Overview
=================
Brief Summary
-----------------
A device for measuring body composition with a small electric current, at 200 μA, (bioelectrical impedance analysis, or BIA) was designed. The goal of this study is to validate the device against several existing devices using the same method of measuring body composition with a small electric current.

Detailed Description
-----------------
The measurement of individual segments, instead of the body as a whole, with BIA has not been fully explored. The prototype device is capable of directly measuring multiple body segments (arm, trunk, and leg) simultaneously, and the final version will be able to provide composition about each segment and the body as a whole. Current devices on the market are not capable of this. The reference devices will be used to measure segments as well, and the raw measurements will be compared. The Multiscan 5000 provides segmental body composition for the arm or leg, but requires measuring it separately. The SFB7 is designed only for measuring the whole body, but the raw impedance measurement data from the SFB7 can be used for comparison, as the impedance magnitudes of individual segments will be within its measurement range. The Seca 514 doesn't directly measure segments, but it can provide segmental data by measuring from hand to foot, then from hand to hand, and finally from foot to foot. It then uses these measurements, and assumptions about the subject to provide segmental composition data.

Official Title
-----------------
Development of a Segmental Bioelectrical Impedance Spectroscopy Device for Body Composition Measurement

Conditions
-----------------
Medical Device

Intervention / Treatment
-----------------
* Device: Bioelectrical Impedance Monitor


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Students from Georgia Southern University Exclusion Criteria:
Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| subj 1<br>Three commercially available BIA devices vs SBIS device | Device: Bioelectrical Impedance Monitor<br>* Subjects had been under the test of three commercially available devices and the device that the investigators had developed.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Impedance values from each devices | Bioelectrical impedance values from three devices were measured and recorded. | One year IRB period | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Bioelectrical Impedance spectroscopy, Body compositions, Segmental Bioelectrical impedance spectroscopy
Swiss Primary Sclerosing Cholangitis Cohort Study

Study Overview
=================
Brief Summary
-----------------
Research project in which biological material is sampled and health-related personal data is further used and collected. Coded data are used.

Detailed Description
-----------------
The investigators wish to collect high quality prospective data on a rare disease in order to elucidate epidemiology, natural history, response to treatment and outcome. In addition, a biobank allows addressing specific scientific issues on a variety of open questions. The cohort will provide a platform for carrying out scientific research projects on PSC. In addition, the cohort will allow collaborations with reference networks on PSC abroad

Official Title
-----------------
Swiss Primary Sclerosing Cholangitis Cohort Study

Conditions
-----------------
Cholangitis, Sclerosing

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Patients diagnosed with PSC according to established criteria (European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of cholestatic liver diseases) of any age. Patients not fulfilling such criteria but still diagnosed with PSC in a hepatology referral centre can be included patients living in Switzerland Exclusion Criteria: N/A
Sexes Eligible for Study
-----------------
All

Study Plan
=================
How is the study designed?
-----------------
What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Disease course | Observing disease course | 3 years | 
| Disease features | Observing disease features in Swiss population and see if they are similar to other countries' | 3 years | 
| Response to treatment | Observing response to treatment | 3 years | 
| Overall survival | Observing overall survival | 3 years | 
| Transplantation-free survival rate | Observing transplantation-free survival rate | 3 years |
Pediatric Pneumonia Lung Ultrasound

Study Overview
=================
Brief Summary
-----------------
The purpose of this study is to evaluate the impact of LUS on the diagnosis and management of childhood pneumonia in developing countries

Official Title
-----------------
Evaluation of Impact of Lung Ultrasound (LUS) on Management of Pneumonia in Low-resource Settings

Conditions
-----------------
Pneumonia, Acute Respiratory Infection

Intervention / Treatment
-----------------
* Device: Lung ultrasound


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria (chest indrawing cases): Male or female, 2 through 23 months of age Cough <14 days or difficulty breathing Visible indrawing of the chest wall, with or without fast breathing Ability and willingness of child's caregiver to provide informed consent and to be available for follow-up for the planned duration of the study, including accepting a home visit if he/she fails to return to the study facility for a scheduled follow-up visit Inclusion Criteria (non-chest indrawing controls): Male or female, 2 through 23 months of age Cough <14 days or difficulty breathing Ability and willingness of child's caregiver to provide informed consent and to be available for follow-up for the planned duration of the study, including accepting a home visit if he/she fails to return to the study facility for a scheduled follow-up visit

Ages Eligible for Study
-----------------
Minimum Age: 2 Months
Maximum Age: 23 Months

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Mozambique, cases<br> | Device: Lung ultrasound<br>* Lung ultrasound will be performed on all children to investigate imaging patterns characteristic of pneumonia.<br>|
| Mozambique, controls<br> | Device: Lung ultrasound<br>* Lung ultrasound will be performed on all children to investigate imaging patterns characteristic of pneumonia.<br>|
| Pakistan, cases<br> | Device: Lung ultrasound<br>* Lung ultrasound will be performed on all children to investigate imaging patterns characteristic of pneumonia.<br>|
| Pakistan, controls<br> | Device: Lung ultrasound<br>* Lung ultrasound will be performed on all children to investigate imaging patterns characteristic of pneumonia.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| LUS findings at enrollment |  | 8 hours | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Repeat LUS findings |  | 30 days | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
pneumonia, diagnostic, ultrasound, Pakistan, Mozambique
Identification of Preoperative Parameters to Predict Acute Kidney Injury Risk Following Vascular or Digestive Surgery

Study Overview
=================
Brief Summary
-----------------
The study aims to identify the preoperative parameters associated with the risk of postoperative acute kidney injury (in particular the parameters of the SPARK score) in patients of the Besançon University Hospital who have undergone digestive or vascular surgery.

Official Title
-----------------
Identification of Preoperative Parameters to Predict Acute Kidney Injury Risk Following Vascular or Digestive Surgery

Conditions
-----------------
Acute Kidney Injury

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Digestive surgery or vascular surgery at Besancon University Hospital between 01/01/2019 and 31/12/2019 (retrospective) or between 01/01/2023 and 31/12/2023 (prospective) Exclusion Criteria: No preoperative creatinine value Outpatient surgery Surgery other than digestive or vascular (organ procurement surgery/nephrectomy surgery/renal transplantation) Kidney/urinary tract surgery Arteriovenous fistula surgery End-stage renal disease or renal replacement therapy, except for renal transplant patients Acute kidney injury KDIGO≥1 within 2 weeks before surgery Patients in need of emergency surgery for ongoing haemorrhage Legal incapacity or limited legal capacity Subjects with no social security coverage.

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Patient with a digestive surgery procedure<br> | |
| Patient with a vascular surgery procedure<br> | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Occurrence of acute kidney injury | Occurrence of acute kidney injury within 2 weeks after surgery, as defined by the 2012 KDIGO (Kidney Disease: Improving Global Outcomes) criteria | 2 weeks after surgery | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Vascular Surgical Procedures, Digestive surgery, Vascular surgery